Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis
Abstract Background Helicobacter pylori (H. pylori) infection may affect the efficacy of immunotherapy and adjuvant chemotherapy in gastric cancer patients. However, the role of H. pylori infection in neoadjuvant chemotherapy in patients with locally advanced gastric cancer (LAGC) remains unclear. T...
Saved in:
Main Authors: | Bin Zhong, Zhizhong Xiong, Jiabo Zheng, Saddam Ahmed Mohamed, Jiachen Sun, Dayin Huang, Zijian Deng, Jianping Guo, Junsheng Peng, Huashe Wang, Lei Lian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13494-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis
by: Yonghe Chen, et al.
Published: (2025-01-01) -
Gastric precancerous conditions or lesions and Helicobacter pylori
by: M Areia, et al.
Published: (2024-09-01) -
Carcinoembryonic antigen trajectory predicts pathological complete response in advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2025-02-01) -
Helicobacter pylori: pathogenesis
by: P. Sabanas, et al.
Published: (2024-09-01) -
Review of non-Helicobacter pylori Helicobacter species: Insights into pathogenesis, epidemiology, and clinical implications
by: M. Kroiß, et al.
Published: (2024-09-01)